Inactive Instrument

Press Releases Avalanche Biotechnologies Inc Nasdaq

Equities

US05337G1076

Press Releases

Unlock all the news: Be the first to know and act before the market!

Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilard Kiss as a Member of the Board of Directors	12/06	AQ
Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilárd Kiss as a Member of the Board of Directors	11/06	AQ
Diabetic Retinopathy Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	15/05	AQ
Adverum Biotechnologies: Q1 Earnings Snapshot	10/05	AQ
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights	10/05	AQ
Adverum Biotechnologies to Participate in Upcoming May Investor Conferences	06/05	AQ
Adverum Biotechnologies to Participate in Upcoming May Investor Conferences	03/05	AQ
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting	26/04	AQ
Adverum Biotechnologies: Q4 Earnings Snapshot	19/03	AQ
Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates	19/03	AQ
Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference	29/02	AQ
Adverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	12/02	AQ
Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Trial of Ixo-vec in Patients with Wet AMD	08/02	AQ
Adverum Biotechnologies Announces $127.5 Million Private Placement Financing	05/02	AQ
Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Results on February 8, 2024	02/02	AQ
Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer	29/01	AQ
Adverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meeting of the Macula Society	08/12	AQ
Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx Conference	29/11	AQ
Adverum Biotechnologies: Q3 Earnings Snapshot	10/11	AQ
Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights	10/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Avalanche Biotechnologies Inc Nasdaq

Equities

US05337G1076

Press Releases

Filters